Your browser doesn't support javascript.
loading
Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait.
Cai, Yanwei; Franceschini, Nora; Surapaneni, Aditya; Garrett, Melanie E; Tahir, Usman A; Hsu, Li; Telen, Marilyn J; Yu, Bing; Tang, Hua; Li, Yun; Liu, Simin; Gerszten, Robert E; Coresh, Josef; Manson, JoAnn E; Wojcik, Genevieve L; Kooperberg, Charles; Auer, Paul L; Foster, Matthew W; Grams, Morgan E; Ashley-Koch, Allison E; Raffield, Laura M; Reiner, Alex P.
Affiliation
  • Cai Y; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Franceschini N; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Surapaneni A; Department of Epidemiology and Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Garrett ME; Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Tahir UA; Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina.
  • Hsu L; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Telen MJ; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Yu B; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Tang H; Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina.
  • Li Y; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Liu S; School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Gerszten RE; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Coresh J; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.
  • Manson JE; Center for Global Cardiometabolic Health, Departments of Epidemiology, Medicine, and Surgery, Brown University, Providence, Rhode Island.
  • Wojcik GL; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Kooperberg C; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Auer PL; Department of Epidemiology and Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Foster MW; Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Grams ME; Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Ashley-Koch AE; Department of Epidemiology and Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Raffield LM; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Reiner AP; Division of Biostatistics, Institute for Health and Equity, and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Clin J Am Soc Nephrol ; 18(11): 1416-1425, 2023 11 01.
Article de En | MEDLINE | ID: mdl-37533140
BACKGROUND: Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait. METHODS: We measured proteomics ( N =1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait. RESULTS: In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury ( e.g. , hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α -hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58). CONCLUSIONS: We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trait drépanocytaire / Insuffisance rénale Type d'étude: Prognostic_studies Limites: Female / Humans Pays/Région comme sujet: America do norte Langue: En Journal: Clin J Am Soc Nephrol Sujet du journal: NEFROLOGIA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trait drépanocytaire / Insuffisance rénale Type d'étude: Prognostic_studies Limites: Female / Humans Pays/Région comme sujet: America do norte Langue: En Journal: Clin J Am Soc Nephrol Sujet du journal: NEFROLOGIA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique